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PREFACE 
The work of this thesis was carried out between August 2013 and June 2015 at the 
Department of Molecular and Cellular Biology at Kennesaw State University. The nature of 
the work is integrative pulling from biophysics, genetics, neuroscience, and cell and 
molecular fields of biology to aim at a broad scientific inquiry into nervous system 
development in Caenorhabditis elegans. The body of work is partitioned into two main parts: 
Eph-ephrins in C. elegans and biochemical characterization of EFN-4. A final conclusion 
chapter considers the preceding material in a broader integrative biological sense.  
With the exception of contributions by fellow laboratory members (see Acknowledgments 
and Contributions), this thesis is the result of my own work. The work presented in this 
thesis is only being submitted to Kennesaw State University and no part of it is submitted to 
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 efn-4 does not regulate axon outgrowth cell autonomously 
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 AIY interneuron axonal growth cones present at lima bean stage of embryonic 




































 AIY interneuron axon outgrowth defects in Eph receptor vab-1 mutant and ephrin 
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 Body morphology defects in efn-4, ephrin ligand and vab-1, Eph receptor mutants 
























 pSecTag A (Invitrogen) Mammalian expression vector used in construction of EFN 








 BLI sensogram of EFN-1 and EFN-4 ephrin ligands interacting with the canonical 




 Western blot of HEK293T transfected cell lysates for Fc control, EFN-1, EFN-4, PLAP 
control and VAB-1 proteins
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 Co-immunoprecipitation western blots of EFN-1, EFN-4 interacting with LAD-2 and 
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Eph receptor tyrosine kinase and their ephrin ligands are required for the organization of 
neuronal connections, cell migration during embryogenesis, and topographic map formation 
(Flanagan and Vanderhaeghen, 1998). EphR-ephrin signaling is a cell contact dependent 
interaction that classically refines cellular movement via repulsive mechanisms. Eph/ephrin 
gradients direct neuronal projections through repulsive mechanisms in the formation of the 
visual topographic map. The retinal ganglion cells send axonal projections along the retinal 
temporal-nasal axis to the superior colliculus that are directed by gradients of EphR-ephrins. 
Retinal ganglion cell (RGC) axons with high levels of EphA receptors target to areas of the 
superior colliculus (SC) with low levels of ephrin-As whereas RGC axons with low levels of 
EphA receptors are targeted to areas with high levels of ephrin-A expression consistent with 
repulsive action of axonal refinement (Feldheim and O’Leary, 2010). Topographic mapping of 
neurons in the thalamocortical (TC) map and the corticospinal tract (CST) map depend on 
the functional tyrosine kinase domain of the Eph receptor. In mouse studies of 
thalamocortical (TC) mapping the EphA4 receptor tyrosine kinase domain was found to be 
necessary for axonal repulsion at the midline (Dufour et al., 2006). Prevention of 
corticospinal tract projection re-crossing over at the midline is necessary for unilateral motor 
control (Kullander et al., 2001). The EphA4 receptor was found to bind ephrin-B3 ligand in a 
repulsive action to effect corticospinal tract refinement and prevent crossing over at the 
midline thus ensuring proper alternate gait and unilateral motor control (Kullander et al., 
2001) Despite evidence for kinase-dependent Eph receptor function there are studies 
supporting kinase-independent functions as well (Dufour et al., 2006; Kullander et al., 2001; 
Grossman et al., 2013).  
 
Eph receptors and ephrin ligands in humans may be divided into subclasses: EphA and 
EphB class receptors and ephrin-A class and ephrin-B class ligands. Ephrin-A ligands are 
GPI (glycosylphosphatidylinositol) anchored to the cell membrane and do not pass through 
the plasma membrane to the intracellular side. Ephrin-B class ligands on the other hand 
contain a trans-membrane domain. Promiscuity in Eph/ephrin binding exists but is restricted 
to intrasubclass interaction and is rarely seen in intersubclass interactions (Himanen et al., 
2007). However EphA4 receptor displays the greatest diversity in binding promiscuity with 
the capacity to bind to all ephrin-A and ephrin-B ligands (Pasquale, 2004). EphR-ephrins can 
transduce cellular signals in both the EphR expressing cell and the ephrin ligand-expressing 
cell by what is known as bidirectional signaling. Eph receptors contain an intracellular 
functional kinase domain that transduces the signal received from the ephrin ligand on the 
extracellular side of the cell to the intracellular environment. Eph receptor tyrosine kinases 
display ligand-induced cross-phosphorylation and subsequent activation of the kinase 
domain. Ephrin-A ligands are tethered to the plasma membrane by a GPI anchor and 
present no immediately apparent means of transducing a signal from the receptor-bearing 
cell to the intracellular side of the ligand-bearing cell. Upon interaction with the cognate 
EphA receptor ephrin-A ligands classically transmit a repulsive signal in the reverse signaling 
cell. Repulsive reverse signaling is proposed to act via proteolytic cleavage by ADAM-type 
metalloproteinases that recognize ephrin-A ligands in contact with clustered EphA receptors 
(Hattori et al., 2000). Ephexin-1 (Eph- Interacting Exchange protein) upon ephrin-induction 
acts as a guanine nucleotide exchange factor (GEF) to activate RhoA (Ras homolog gene 
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family, member A), a GTPase protein that regulates actin cytoskeleton rearrangement. 
Ephrin-A stimulates the EphA receptor, which in turn modulates the activity of ephexin 
leading to RhoA activation and subsequent cell morphology changes. The activation of 
ephexin via ephrin-A stimulated EphA forms the basis of growth cone motility and acts in a 
repulsive manner to initiate growth cone collapse and movement of the cell away from the 

























Figure 1. Schematic of EphR/ephrin Signaling A. Domain Organization of EphR and ephrins. A. Classically 
ephrin-A-ligands bind to EphA-receptors and ephrin-B-ligands bind to EphB-receptors. The ephrin-As are GPI 
anchored to the cellular membrane whereas ephrin-Bs have a transmembrane region with a cytoplasmic tail. 
EphA and EphB are receptor tyrosine kinases (RTK) and canonically bind to their respective ligands in a “lock-
and-key” manner. Ephrin-As may bind with co-receptors that mediate repulsive and attractive signaling. 
Ephrins and EphRs are capable of bidirectional signaling. The cell bearing the ephrin may receive cues from 
the EphR imparting reverse signaling; similarly the EphR may receive cues from the ephrin in forward signaling. 
B. Topographic Mapping. Dual gradients of ephrins and EphR in the retina and superior colliculus guide retinal 
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ganglion cell axons. Regions of high levels of EphAs target regions of low levels of ephrin-As consistent with 
repulsive mechanisms in the topographic mapping of the visual system. (GPI, glycosylphoshatidylinositol, RBD, 
receptor binding domain, PDZ, (PSD-95/Dlg/ZO-1) domain; a protein module that binds the C termini of 
membrane proteins, TM, transmembrane domain, JM, juxtamembrane domain) C. Cell Migratory Cues. Ephrins 
and EphR guide cellular migration through an array of signaling mechanisms. Classically when ephrin-A is 
bound to its receptor EphA a repulsive forward signal is received by the EphA-receptor bearing cell. Adhesion 
may occur when the ephrin-A is bound to the EphA-receptor that is bound in cis with another ephrin-A. Co-
receptor binding to the ephrin-A ligand may mediate cellular attractive and repulsive cues.  The ephrin-Bs and 
their respective EphB-recptors impart repulsive cues to mediate cell migration and axon tracking. 
 
 
Modeling EphR-ephrin interactions in models systems 
 
Humans possess ten EphA receptors: EphA1-EphA10 and six ephrin-A ligands: ephrin-A1-
ephrinA6 as well as six EphB receptors: EphB1-EphB6 and three ephrin-B ligands: ephrin-
B1-ephrin-B3 (Himanen et al., 2007). Many tissues express multiple EphRs and ephrins 
making it difficult to understand the roles of individual genes during development and 
disease. The nematode C. elegans only contain a single EphA receptor and four ephrin-A 
ligands yet share sequence homology with all of the human Eph receptors and ephrin 
ligands (WormBase). Sequence homology between C. elegans and Homo sapiens makes the 
study of EphA-ephrin interactions in the nematode an applicable investigation for relation to 
human nervous system development and disease.  
 
Table 1. EphR/ephrins are conserved from H. sapiens to C. elegans 
 H. sapiens C. elegans 
EphA receptor EphA1 – EphA7 vab-1 
ephrin-A ephrin-A1 – ephrin-A5 efn-1 – efn-4 
  
A human ephrin-A homolog found in C. elegans, efn-4, acts via a non-canonical signaling 
mechanism to regulate neuronal development in C. elegans. The efn-4 ligand is GPI 
anchored and contains a receptor-binding domain that is exposed to the extracellular 
matrix. The true receptor to efn-4 remains to be elucidated as forward genetic analysis of 
the efn-4 gene reveals that efn-4 does not bind solely to the canonical Eph receptor in C. 
elegans, vab-1 and exhibits independent phenotypes to that of vab-1 Eph receptor (Chin-
Sang et al., 2002). Body morphology defects arise in both Eph receptor and ephrin ligand 
mutant nematodes. vab-1 mutants have “head-notch” defects along with low penetrance 
aberrant tail morphology. efn-4 mutant worms do not have the “head-notch” defect but 
rather display a “bulging-tail” morphology. vab-1 mutants also show aberrant axonal 
outgrowth defects (Mohamed and Chin-Sang, 2006). Whether efn-4 functions with vab-1 in 
this context is not known.  
 
We have identified roles for efn-4 in the axon outgrowth of AIY interneurons. This 
interneuron pair, AIYL and AIYR, are located in the head of C. elegans. AIYL/R interneurons 
receive and process synaptic output from the amphid sensory neurons. Of the first layer 
amphid interneuron pairs: AIA, AIB, AIY, and AIZ, the AIY interneurons play an integrative 
role in sensory information processing. The AIY interneurons are important in behavioral 
plasticity paradigms where ablation of the AIY interneurons results in the animal’s inability to 
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find the location of food given thermal or chemical cues from the environment. AIY 
interneurons integrate signals from the AWC and AFD neurons that stimulate migration to 
warmer temperatures (Ohnishi et al., 2001). Thermotaxis impairment results from disruption 
of the AIY interneurons that primarily drive warm-seeking (thermophilic) locomotion changes 
to cryophilic behavior (Mori and Ohshima, 1995).  Imbalance between activation of the AIZ 
neurons driving cold-seeking (cryophilic) movement and AIY neurons driving themophilic 
movement leads to defective motor output in response to thermal signals and starvation (de 
Bono and Maricq, 2005; Ishihara et al., 2002; and Ohnishi et al., 2001). The aim of this thesis 
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C. elegans embryonic development 
 
The epidermis largely controls morphogenesis in the developing C. elegans embryo. The 
hypodermis, or epidermis, is a single epithelial layer that surrounds the body of the animal. 
Morphogenesis of the epidermis involves cell-cell interaction with the developing nervous 
system (Chisholm A.D. and Hardin J., 2005). The developing nervous system and the 
epidermis come into direct contact during embryogenesis. Ventral enclosure requires both 
an intact epidermal layer and substrate neuroblasts. We hypothesize that an efn-4-
dependent interaction between neurons and hypodermal cells is required during 





Figure 2. Embryogenesis in Caenorhabditis elegans. Image adapted from WormAtlas. 
 
 
efn-4 mutant worms exhibit neuroblast cell migration defects leading to delayed closure of 
the ventral cleft (Chin-Sang et al. 2002; Hudson et al. 2006). Following cleft closure, the 
ventral neuroblasts act as a substrate for epithelial cell rearrangements. These epithelial cells 
are born on the dorsal and lateral sides of the embryo then undergo epiboly, extending and 
enclosing the embryo about 300 minutes into development. Ventral epithelial cells 
subsequently make contact with their contra-lateral partners, form tight junctions, then 
contract, squeezing the embryo from an ovoid into a vermiform shape (Figure 2) (Chin-Sang 
and Chisholm, 2000). There is no developmental checkpoint to this process, so if the ventral 
cleft remains open at enclosure, the epithelial cells fail to make contact, but will still undergo 
the contraction process, causing loss of internal cells and embryonic lethality.  
 
Ventral enclosure requires both an intact epidermal layer and substrate neuroblasts.  In the 
C. elegans EphR mutation, vab-1(e2027) ventral enclosure frequently fails because the 
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epidermis is not properly arranged into an epidermal sheet that ought to enclose the embryo 
by epidermal epiboly. Neuronal-to-epidermal signaling is thought to provide the necessary 
cues for epidermal cell movements (Ikegami et al., 2012). vab-1 mutants display a defective 
neuronal precursor substrate positioning. Without a permissive neural substrate the 
epidermal cells are unable to properly migrate and morphological defects are observed. Our 
central question is whether EphR – ephrin interaction between the neuroblasts and the 
hypodermis is required for correct epithelial migration  
 
In the C. elegans EphR mutation, vab-1(e2027), movement of the ventral neuroblasts are 
defective and the ventral cleft remains enlarged. If the ventral cleft is persistently enlarged 
epidermal enclosure cannot ensue due to a defective neuroblast substrate. Mutations in the 
ephrin-A gene efn-4 cause slight delay in neuroblast migration and results in epidermal 
enclosure defects. Nematodes that survive embryogenesis despite delayed neuroblast 








Figure 3. Still capture of AIY interneuron development. Dorsal view, bottom is left side of the embryo, spheres 
indicate individual nuclei. Black spheres are A.  AIYL and B. AIYR. Surround spheres nuclei of cells with 
acquired tissue identities. Tan spheres hypodermis (hexadecimal (hex code) color: dcc2ac), green sphere 
muscle cell (hex code: 336600), burnt brown spheres epithelial seam cells (hex code: cc6633) (still capture 
from WormAtlas movie rendition by A. Santella and Z. Bao, 2012).  
 
 
AIY interneurons take on their identity during mid-embryonic development approximately 80 
minutes post-fertilization and come into direct contact with epithelial tissue during 
embryogenesis (Figure 3). efn-4 mutations cause defects in AIY interneuron morphology in 
addition to previously published hypodermal defects. efn-4 function is not fully understood 
in the context of nervous system development and disease. We hypothesize that the 
epidermal cells are in direct cell-cell contact with neuroblasts to induce proper fate 
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MATERIALS AND METHODS 
 
C. elegans strains were grown on nematode growth medium (NGM) plates at 22°C (Brenner, 
1974). The following strains and mutations were used in the course of this work: N2 Bristol 
(wild type); vab-1(e2027)II; efn-4(bx80)IV; efn-4(e1746ts)IV; efn-4(e660)IV; otIs76[pttx-3p::kal-
1 + unc-122p::GFP]mgIs18[pttx-3::GFP]IV; lad-2(tm3056)otEx331[lad-2[::GFP + pha-1(+)]IV; 
oxTi420[eft-3p::mCherry::tbb-2-3’UTR + Cbr-unc-119(+)].  
 
Assay of AIY interneuron morphology through larval development  
 
efn-4(bx80)mgIs18otIs76 embryos were staged for Zeiss confocal microscopy imaging. For 
each animal assayed images were taken of the AIY interneurons for each of the larval stages 
of that animal; L1/L2/L3/L4. The nematode was mounted onto a microscope slide and 
rescued after AIY image capture with GFP channel fluorescence. The animals were rescued 
by mouth-pipetting M9 buffer onto the microscope slide and aspirating the suspended 
nematode off the microscope slide and onto the housing bacteria plate. Animals were 
allowed to molt to the next stage of larval development. Animals at subsequent larval stages 
were recaptured, AIYs imaged and the animal rescued with the same methodology for each 




The baseline strain used in rescue assays was otIs76[pttx-3p::kal-1 + unc-
122p::GFP]mgIs18[pttx-3::GFP]efn-4(bx80). The ttx-3 promoter is an intronic enhancer 
element in the ttx-3 gene that drives gene expression in the AIY neurons alone (Altun-
Gultekin et al., 2001). kal-1 is the C. elegans ortholog of the human KAL-1 gene, which is 
mutated in X-linked Kallmann Syndrome (Bülow et al., 2002 and Rugarli et al., 2002). Over-
expression of kal-1 causes cell-autonomous ectopic axon branching.  
 
C. elegans microinjection is performed by injection of the plasmid DNA into the syncytial 
gonad of a gravid (≥ 1 day old) hermaphrodite with a single row of embryos visible. The tip 
of a micropipette pulled capillary needle is filled with the microinjection mix and mounted 
onto a micromanipulator attached to a stabilized compound microscope equipped with 40X 
and 10X objectives. Coverslip-pads are made with 2% agarose dried overnight as a pad to 
prevent movement of the hermaphrodite upon injection. Hermaphrodites are picked and 
placed onto a small amount of halocarbon oil to prevent desiccation. The microinjection 
needle is inserted at a 45° angle into the distal syncytial gonad and the plasmid DNA 
microinjection mix injected at 15-40 psi depending on the relative size of the tip opening. 
Injected hermaphrodite are rescued with M9 buffer (physiological buffer) onto fresh NGM 
seeded plates. Plates are screened for transgenic progeny expressing fluorescent protein 
marker plasmid via the dissecting microscope equipped with fluorescence. Progeny 
expressing the transgene are moved to a separate plate and allowed to self-fertilize to 
stabilize an independent transgenic line (Figure 4). The final microinjection mix plasmid 
concentration of all lines was kept at a constant 50ng/μl where pBlueScript was added in 
some cases to bring the final concentration to the constant value. 
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Tissue-Specific Transgenics:  
 
efn-4 cDNA expression was driven by the tissue specific promoter in each of the transgenic 
lines: AIY-specific, pan-neuronal, hypodermal, pharyngeal, and body wall muscle. The elt-
3::efn-4 genetic construct was injected at 5ng/μl into efn-4(bx80) mutant animals with sur-
5::gfp as a hypodermal injection marker at a concentration of 20ng/μl and an AIY injection 
marker; ttx-3::rfp at 25ng/μl. The myo-3::efn-4 genetic construct was injected at 10ng/μl into 
efn-4(bx80) mutant animals with myo-3::Cherry as a body wall muscle injection marker at a 
concentration of 25ng/μl. And the pharyngeal transgenic line was constructed with the myo-
2::efn-4 (pMH853) at 10ng/μl and myo-2::mCherry pharyngeal marker at 20ng/μl. See 
Supplemental data for chart details of transgenic line construction. All injection constructs 
were injects at a total of 50ng/μl into the syncytial distal gonad of a gravid hermaphrodite 
and the transgenic progeny selectively breed. 
 
Neuronal efn-4: 
efn-4 cDNA was driven by an unc-119 pan-neuronal promoter to assay for cell-autonomous 
function of ephrin-4 in AIY interneuron morphology. The AIY promoter ttx-3 was used to 
drive efn-4 cDNA to the AIY interneuron specifically to assay for cell-autonomous effects via 
the AIY interneurons. ttx-3::rfp  was used as the AIY interneuron marker.  
 
Genomic efn-4:  
Genomic rescue strains were constructed from the genomic plasmid of efn-4 (pCZ148) 





Figure 4. Microinjection technique. Plasmid marker and plasmid DNA was injected into the distal gonad arm of 
a gravid adult hermaphrodite worm. 
 
 
	   	   	  
	  




Neuroanatomy was scored on the Zeiss LSM700 Confocal Microscope via reporter gene 
constructs expressed in transgenic animals. mgIs18otIs76 [ttx-3p::GFP; pttx-3p::kal-1 + unc-
122p::GFP] was the background strain of the transgenic lines. The AIYR/L interneurons were 
visualized on the confocal microscope via the reporter construct expressing either GFP or 
mCHERRY driven by ttx-3 promoter. ttx-3 encodes for a LIM homeodomain protein that acts 
early in embryonic development and is necessary for AIY interneuron function. Axonal 
branches in AIY caused by kal-1 overexpression (otIs76) were scored as protrusions from 
the axon as “ectopic branches” where the protrusion was defined as a branch if the length 
exceeded 5 microns in length. Aberrant axonal outgrowth was scored as “short-stop” if 
axonal projections failed to reach their terminal target. AIYR/L interneurons extend axonal 
projections from the cell body that meet at the central plexus and extend further, wrapping 
around the pharyngeal bulb, and form at gap-junction connection at the terminal ends. A 
gap or “short-stop” of perceptible visible distance (visible resolution of greater than 3 
microns) was determined to be an axonal outgrowth failure. Distance was measure with the 
ZEN Blue software tools.  
Selection of Hypodermal Expression  
To ensure expression of efn-4 was being driven to the epidermal tissue the reporter 
construct sur-5::gfp was concurrently injected into the syncytial gonad of the adult 
hermaphrodite. The resultant transgenic nematodes may present as mosaic transgenics 
where the expression of elt-3::efn-4 and sur-5::gfp is only expressed in a subset of tissue 
types. This phenomenon is due to the nature in which extrachromosomal arrays behave 
during mitosis. Following injection of the cloned DNA, extrachromosomal arrays form in the 
resultant transgenic animal that are freely duplicated and occasionally do not segregate into 
one of the daughter cells presenting a transgenic nematode that is mosaic in expression of 
the gene (Lackner et al., 1994; Hedgecock and Herman, 1995). sur-5::gfp is also a nuclei 
marker that is located in most all cells rather than a hypodermal specific marker (Gu et al., 
1998). To circumvent this mosaic expression pattern transgenic animals were screened 
post-image capture for sur-5::gfp expression in the hypodermal tissue.  
The hypodermis is seen as a thin layer of hypodermis that in continuous along the lateral 
and dorsal surface and presents with patterned expression on the animal. See Figure 5 
below for hypodermal expression pattern in the anterior portion (head) of C. elegans.  gfp 
expression in the hypodermal cells ensured efn-4 was being expressed in the correct 




	   	   	  
	  






Figure 5.  Hypodermal nuclei of the head. Localization of the anterior hyp cells. Positions of the epithelial cells 
are stereotyped with prominent hyp cell positioned in a continuum along the lateral and dorsal most periphery 




Statistical significance was determined using the Z-test where the generated p-value level of 
significance is marked with a single asterisk (*) for values p<0.05, two asterisks for values 
0.001<p<0.01, and three asterisks for values p<0.001 where the alpha level is determined to 
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RESULTS AND CONCLUSIONS 
 
The C. elegans ephrin efn-4 is required for AIY neuron axon outgrowth  
 
The AIY interneurons are a pair of bilaterally symmetric sensory integrating neurons with cell 
bodies located at the posterior end of the pharyngeal bulb that send axonal projections 
anteriorly (Figure 6). The AIYR/L cell bodies are born in mid-embryogenesis and extend 
cellular protrusions (axonal projections) into the extracellular matrix (ECM). The axonal 
projections must navigate through a chaotic extracellular environment and reach the 





Figure 6. efn-4 mutants have defects in AIY interneuron outgrowth. AIYR/L are a pair of bilaterally symmetric 
interneurons that have cell bodies proximal to the posterior pharyngeal bulb that meet at a central plexus and 
wrap around in the nerve ring to meet their contralateral partner in a gap-junction connection. In wild type AIY 
interneuron morphology axons project from the cell body and extend to the intended terminal position in 
connection with the contralateral axon. efn-4(bx80) mutant animals exhibit premature termination of the axonal 
projections and the axons fail to meet their contralateral partners resulting in a “short-stop” or “gap” 
morphology characteristic of the aberrant axonal outgrowth phenotype of efn-4 mutant nematodes. 
Arrowheads point the efn-4 induced premature axon termination. Scale bar = 5μm. 
 
 
AIYR/L axons in a wild type nematode extend from the cell body to a central plexus and 
then wrap around the pharyngeal bulb to meet the contralateral partner in a synaptic 
junction. This developmental process is not a trivial task; the axons must appropriately filter 
and respond to a myriad of guidance cues in the extracellular environment. Netrins and the 
slit/robo pathway, semaphorins, heparan sulphate proteoglycans and ephrins and their Eph 
receptors are some of the molecules that regulate axon outgrowth in a developing nervous 
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system. We set out to examine the role of efn-4 in axon outgrowth by asking if efn-4 
regulated axonal projections in the AIY interneurons.  
 
Our data shows that in the AIYR/L interneurons efn-4 is a major factor influencing axon 
outgrowth. efn-4 mutants display gross axon outgrowth defects characterized by premature 
termination of axonal projections. The axons stop short and a “gap” is seen in this pair of 
interneurons upon microscopy observation. This “short-stop” or “gap” phenotype is highly 
penetrant across efn-4 mutant alleles (bx80, e1746ts, e660) at approximately 50% aberrant 
outgrowth seen (Figure 7) (N>50). bx80 is likely to be a null mutation and is a deletion of the 
second exon of efn-4. Both e1746ts, a temperature sensitive allele, and e660 are weak 
mutations caused by a missense alteration in the receptor binding domain (Chin-Sang et al., 
2002). In Figure  6 failure of the AIY interneuron axonal projections in an efn-4 mutant animal 
is compared to that of a wild type. Zeiss confocal microscopy was used to capture the 
images with a green-fluorescent-protein (GFP) reporter construct driven by ttx-3 a LIM-





Figure 7. efn-4 mutants display axon outgrowth defects. Multiple alleles of efn-4 mutants display AIY outgrowth 
defects. The aberrant axon outgrowth phenotype observed is due to the efn-4 gene rather than to some other 
nearby loci. All efn-4 mutants are in a kal-1(gf) background. N ≥ 50.  
 
 
Multiple alleles of efn-4 mutants (e1746ts, bx80, e660) display axon outgrowth defects in the 
AIY interneurons indicative that the phenotypic mutation is indeed attributable to the efn-4 
locus rather than to some other nearby loci (Figure 7). From these observations we can 
remark that efn-4 is indeed required to regulate axonal outgrowth in the AIY interneurons.  
We used the efn-4(bx80) mutant strain for the remainder of this thesis. 
 
Taken together with the data that efn-4 is required for axon outgrowth with previous 
literature showing that efn-4 is required during embryonic morphogenesis we sought to test 
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the hypothesis that efn-4 is required during embryogenesis to regulate axonal outgrowth 
(Chin-Sang et al., 2000). We asked whether axon outgrowth was due to efn-4 acting as a 






Figure 8. Diagram axonal projections failing to make contact with the intended target cell.   Possible fate 
outcomes of a path-finding cell and the modes of bringing about each outcome are shown in the illustration. 
The axonal projections may A. extend normally into the extracellular matrix and meet the intended target cell 
but C. fail to maintain contact with that cell and retract resulting in an axon “gap” to the intended target or B. 




To address whether efn-4 acts as a maintenance cue, the AIY interneurons of a given 
nematode were imaged at each larval stage and scored for consistency of morphology. If 
the axon outgrowth morphology changed from one larval stage to the next then it may be 
concluded that EFN-4 may act as a maintenance cue during larval development. EFN-4 is 
not required as a maintenance cue in AIY interneuron axon outgrowth. AIY interneuron 
morphology for each larval stage of development was acquired via the Zeiss confocal 
microscope. The same animals were imaged at each larval stage L1, L2, L3, and L4 N of 15 
for each category: aberrant AIY outgrowth and wild type AIY outgrowth. No difference was 
seen in AIY morphology for each stage of larval development in the EFN-4 mutant strain 
mgIs18otIs76bx80. EFN-4 does not act as a maintenance cue during larval development as 
the morphology of the AIY interneurons remained the same. If there was a “gap” observed in 
the L1 stage, this “gap” persisted into adulthood. If the morphology of the AIY interneurons 
was wild type then the axonal projections did not retract into a “gap” phenotype but rather 
remained wild type. From these data, we conclude that efn-4 acts to mediate AIY 
interneuron outgrowth during embryonic development and that it does not act as a 
maintenance cue during larval development.  
 
To assay whether the genetic mutant phenotype may be rescued by germ line 
microinjection, we exogenously introduced extrachromosomal arrays of genomic efn-4. 
Transgenic nematodes expressing the genomic efn-4 were confirmed by co-injection marker 
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expression of ttx-3::rfp, which fluorescently labels the AIY interneurons with red fluorescent 
protein (RFP). Introducing extrachromosomal genomic efn-4 in the efn-4(bx80) mutant 





Figure 9. Genomic rescue of efn-4 aberrant AIY interneuron outgrowth. Exogenous expression of genomic efn-
4 plasmid in the efn-4(bx80) background (mgIs18otIs76bx80) significantly rescued the aberrant axonal 
outgrowth defect. pCZ148 plasmid containing the entire efn-4 coding region (~16kb) was concurrently injected 




It is clear that efn-4 plays a role in axon outgrowth but whether this effect is cell-
autonomous (i.e. arising in the neuronal tissue) or non-cell autonomous (i.e. from another 
tissue type) remains an open question. With the confidence that the AIY interneuron aberrant 
axonal outgrowth phenotype may be rescued via microinjection into the germ line we sought 
to address whether efn-4 gene was mediating outgrowth via a cell-autonomous or non-cell-
autonomous manner.  
 
To assay whether efn-4 was acting in the same cell type to which the phenotype is seen 
neuronal specific transgenic lines driving efn-4 were created. AIY interneuron driving efn-4 
via the ttx-3 promoter was constructed to test cell-autonomous function of efn-4 from the 
same exact cell, the AIY interneurons. Pan-neuronal expression of efn-4 was also carried out 
via the pan-neuronal promoter unc-119 driving efn-4 cDNA expression in all neuronal tissue 
in an efn-4(bx80) background. The use of an efn-4 cDNA lacks genomic enhancers and 
promoters, thus ensuring that expression was only driven from the heterologous promoter in 
question. The cDNA of efn-4 was used in all subsequent transgenic line creations of efn-4. 
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Figure 10. efn-4 does not regulate axon outgrowth cell autonomously. Reintroduction of efn-4 cDNA in 
neuronal tissue does not rescue aberrant axonal outgrowth. Expression of efn-4 was driven to global neural 
tissue via the pan-neural promoter unc-119. efn-4 was driven by ttx-3 to give expression in the prototype 
neurons AIYR/L interneurons. Neither pan-neuronal nor AIY specific expression of efn-4 rescued the AIY 
interneuron aberrant axonal outgrowth. 
 
 
To assay cell-autonomous regulation of AIY outgrowth from the same tissue, an AIY 
promoter driving efn-4 was used. This failed to rescue the phenotypes observed, suggesting 
that efn-4 does not act through AIY interneuron tissue to regulate its own outgrowth (Figure  
10). Pan-neuronal expression of efn-4 via the unc-119 promoter reconfirmed this finding 
showing no significant rescue of the aberrant axonal outgrowth phenotype (Figure 10). From 
this it may be concluded that efn-4 does not act cell-autonomously to mediate axon 
outgrowth in the AIY interneurons, suggesting that efn-4 may function non-cell 
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Figure 11.  AIY interneuron axonal growth cones present at lima bean stage of embryonic development 
juxtaposed to hypodermal and pharyngeal cells. The AIY interneurons have clearly visible growth cone 
projection during mid-embryonic development. Seen here in the left panel is the lima bean stage of embryonic 
development of an mgIs18otIs76 embryo and on the right is the fluorescent channel capture of the AIY 
interneurons of the same embryo. White-dashed region represents hypodermal cell position and in red-dash is 
the nascent pharynx of an embryo. The growth cones lie adjacent to the hypodermal tissue.   
 
 
Being that EFN-4 is not required to regulate axon outgrowth during larval stages of 
development we focused on AIY interneuron development during embryogenesis. In Figure 
11 presence of axonal projections from the AIY interneuron cell bodies are clearly visible at 
the lima bean stage of embryonic development (~350 minutes into embryogenesis). The AIY 
interneuron growth cone at this stage of development are juxtaposed to the hypodermal 
tissue supporting the hypothesis that signaling may be from the hypodermal to AIY 
interneuron tissue.  
 
To test the hypothesis that efn-4 acts non-cell-autonomously to regulate axon outgrowth 
tissue specific transgenic lines of efn-4 expressed in pharyngeal tissue, body wall muscle, 
and hypodermal tissues were created (Figures 12, 14, and 16). The respective promoters 
used to drive expression of efn-4 cDNA in each particular tissue were myo-2 (pharyngeal 
tissue), myo-3 (body wall muscle), and elt-3 (hypodermal tissue). myo-2::mCherry, myo-
3::rfp, and sur-5::gfp co-injection markers were used to identify worms that were carrying 
the transgene and also served to identify the source of transgene expression. AIY 
interneuron morphology was scored via GFP marker in the mgIs18otIs76 background or via 
the ttx-3::rfp co-injection marker. The pharyngeal construct included: myo-2::efn-4 myo-
2::mCherry; the musculature construct included: myo-3::efn-4 myo-3::rfp; and the 
hypodermal expression construct included: elt-3::efn-4 sur-5::gfp and ttx-3::rfp. Young L4 
hermaphrodites expressing the desired transgenes were staged a day prior to imaging to 
ensure congruent age of the transgenic nematodes. AIY interneurons were captured with Z-
stacking and scored for morphology and “gap” phenotype by either scrolling through the Z-
stacks or utilizing the 3D rendering capacities of the ZEN software on the confocal 
microscope.   
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Expression of efn-4 cDNA in the pharyngeal tissue partially rescued the AIY interneuron 
outgrowth defect in one of the transgenic lines suggesting that efn-4 may be mediating axon 





Figure 12. Tissue specific expression of efn-4 cDNA in the pharyngeal tissue. efn-4 cDNA was driven by tissue 
specific promoters to particular tissue in an effort to rescue the aberrant AIY interneuron outgrowth phenotype; 
“short-stop” premature termination of axon outgrowth. efn-4 expression was driven in the pharyngeal tissue 
(arrowheads) with the promoter myo-2 promoter and in conjunction with a red fluorescent protein (mCHERRY) 









	   	   	  
	  






Figure 13. efn-4 may be partially mediating axon outgrowth via pharyngeal tissue. efn-4 expression was driven 
in the pharyngeal tissue via the promoter myo-2 concurrently with the reporter construct myo-2::mCherry. 
Partial rescue of aberrant axonal outgrowth was seen in the first line.  
 
 
As the axonal outgrowth phenotype is mediated non-cell-autonomously by efn-4 and occurs 
as an embryonic developmental process we hypothesized that the source of efn-4 may be 
required in the body wall muscle to regulate axon outgrowth in the AIY interneurons (Figure 
14). Cell migration is an intricate process that requires communication between adjacent 
tissues for proper cell movement. The muscle tissue seemed to be a likely source of efn-4 as 
defects in the vab-1 Eph receptor and efn-1 ephrin ligand display defects in muscle cell 






	   	   	  
	  






Figure 14. Tissue specific expression of efn-4 cDNA in body wall muscle. efn-4 cDNA expression was driven by 
a myo-3 promoter to rescue the aberrant AIY interneuron outgrowth phenotype; “short-stop” premature 
termination of axon outgrowth. efn-4 was driven to the body wall muscle (arrows) with the promoter myo-3 and 
the RFP (red-fluorescent-protein) reporter construct myo-3::rfp. AIY interneurons (arrowheads) were visualized 






Figure 15. efn-4 is not required in the musculature to promote axon outgrowth. efn-4 was driven by the body 
wall muscle promoter myo-3. To ensure efn-4 was being driven to the body wall muscle the reporter construct 
myo-3::rfp was concurrently injected with myo-3::efn-4. Expression of efn-4 in the body wall muscle did not 
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Expression of efn-4 in the body wall muscle did not rescue aberrant AIY axonal outgrowth 
(Figure 15). We also sought to test whether the hypodermal tissue as the source of efn-4 
during embryogenesis to regulate axon outgrowth in the AIY neurons. We utilized the 
promoter elt-3 to drive efn-4 expression to early epidermal cells. elt-3 is expressed in all of 
the major hypodermal cells except the lateral seam cells (Gilleard et al., 1999). elt-3 is not 
expressed in the ventral cord motor neurons ensuring non-cell-autonomous expression of 
efn-4. elt-3 is part of a GATA factor transcriptional hierarchy that specifies hypodermal 
development in the embryo. In this hierarchy, elt-3 expression is activated by elt-1 but 
repressed by elt-5 and elt-6 (elt-1, elt-5 and elt-6 each encode GATA transcription factors) 
(Gilleard and McGhee, 2001; Koh and Rothman, 2001). elt-3 has nine GATA sequence motifs 
in its promoter (Liu, 2005). Being that elt-3 is necessary to the development and function of 
the hypodermal cells and is not expressed in the neuronal tissue elt-3 was chosen as the 
promoter to drive efn-4 expression in the hypodermal tissue (Gilleard and McGhee, 2001; 
Dijke and Heldin, 2007).  
 
Upon injection of extrachromosomal DNA into the mutant animal one must be careful that all 
of the resultant transgenic animals are expressing the gene of interest in the desired tissue. 
During mitosis free duplication of parts of the genome or extrachromosomal arrays that form 
following the injection of cloned DNA into the germline occurs and occasionally the 
extrachromosomal arrays do not segregated to one of the daughter cells (Lackner et al. 
1994; Hedgecock and Herman, 1995). Hence to ensure that the transgenic nematode is 
indeed expressing the extrachromosomal array in the hypodermal tissue the expression of 
sur-5::gfp marker permitted filtering of animals that did not express efn-4 in this tissue. 
Worm atlas served as a reference source to identify by morphology the hypodermal cells 










	   	   	  
	  






Figure 16. Tissue specific expression of efn-4 cDNA in hypodermal tissue. efn-4 cDNA was driven by an elt-3 
promoter to rescue the aberrant AIY interneuron outgrowth phenotype; “short-stop” premature termination of 
axon outgrowth. The reporter construct sur-5::gfp was used as a nuclei marker for transgene expression in the 







Figure 17. efn-4 is required in epithelial tissue to regulate axon outgrowth in the AIY interneurons. Expression of 
efn-4 in the hypodermis is sufficient to rescue aberrant AIY interneuron outgrowth. The hypodermal cells lie in 
juxtaposition to the ventral neuroblasts during embryonic develop and may signal to early AIY neurons during 
embryogenesis. efn-4 cDNA expression was driven in hypodermal tissue via the elt-3 promoter. Expression of 
efn-4 in the hypodermal tissue was tracked via a SUR-5::GFP marker driven by sur-5 promoter. This GFP 
fusion protein contains a nuclear localization signal and hence is localized to all nuclei. GFP expression in the 
outermost epithelial nuclei confirm expression of both the reporter construct (sur-5::gfp) and the gene of 
interest (pelt-3::efn-4) in the correct hypodermal tissue. 
 
	   	   	  
	  




We found that expression of efn-4 in the hypodermal tissue via the elt-3 promoter rescued 
the aberrant axonal outgrowth phenotype of the efn-4(bx80) mutant animals to a significant 
level (Figure 17). This agrees with the original hypothesis that efn-4 may be mediating axonal 
outgrowth via adjacent tissue during embryonic development. The outcome of these results 
makes sense as the hypodermal tissue lies directly juxtaposed to the AIY interneurons 
during embryogenesis (Figure 11). Non-cell-autonomous signaling from the hypodermal 
tissue bearing the efn-4 ligand to the AIY interneurons is a supported mechanism of action 
of axon outgrowth in C. elegans nervous system development.  
 
Kallmann Syndrome and Ectopic Branching in the AIY Interneurons  
 
Kallmann syndrome is a genetic disorder marked by anosmia and an inability to undergo 
spontaneous puberty. Anosmin-1 in an important human protein for regulation of cell 
migration, axon guidance, and branching when mutated lead to the X-linked form of 
Kallmann Syndrome. KAL-1 is the C. elegans ortholog to the human anosmin-1 protein and 
has been shown to bind to cell surface heparan sulfate proteoglycans syndecan/SDN-1 and 
glypican/GPN-1 (Hudson et al., 2006). Overexpression of KAL-1 in certain neurons leads to 
an ectopic branching phenotype that is dependent on heparan sulfate proteoglycans (HSPG) 
(Hudson et al., 2006; Bülow et al., 2002). Interestingly efn-4 mutations suppress kal-1(gf) 





Figure 18. efn-4 mutations can suppress kal-1 gain of function induced ectopic branching. kal-1(gf) Kallmann 
Syndrome gene displays an ectopic branching phenotype that is suppressed by mutations in the efn-4 gene. 
Asterisks indicate significant branching (>5 microns). Arrows point to kal-1(gf) induced ectopic branching. 
Arrowheads point to efn-4(bx80) premature axon termination.  
 
 
We decided to investigate the mechanisms of ectopic branch formation into the extracellular 
matrix stemming from the axon body as it pertains to efn-4 expression. Our question was 
whether tissue-specific expression of efn-4 modified the ectopic branching phenotype 
induced by kal-1 overexpression. An assay of the percentage of ectopic branching in the 
tissue-specific expression of efn-4 transgenic lines revealed that efn-4 may indeed play a 
role in not only axonal outgrowth but ectopic branching and in general neurite projection into 
the extracellular matrix.  
 
	   	   	  
	  







Figure 19. kal-1 induced ectopic branching in the AIY interneurons. Ectopic branching in the AIY interneurons 
was assayed for each transgenic line: efn-4 genomic rescue, efn-4 expression in the AIY interneurons, pan-
neuronal efn-4 expression and tissue specific efn-4 expression in the pharyngeal, body wall muscle, and 
hypodermal tissues. Ectopic branching was significantly suppressed when efn-4 was driven to the AIY 
interneurons for one particular transgenic line. And expression of efn-4 in the body wall muscle enhanced 
ectopic branching for all three lines. All transgenic rescue lines are in the background kal-1(gf) background 
strain mgIs18otIs76bx80.  
 
 
Loss of efn-4 in a kal-1(gf) background suppresses kal-1 overexpression ectopic branching. 
We wanted to know if efn-4 expression tissue specifically had any affect on ectopic 
branching in the kal-1 overexpression model. We found that genomic rescue expression of 
efn-4 significantly enhanced the ectopic branching phenotype in one of the genomic rescue 
lines. Expression of efn-4 cell-autonomously in the AIY interneurons led to a suppression of 
ectopic branching in one of the lines scored. Interestingly, expression of efn-4 in the body 
wall muscle led to enhanced ectopic branching in all three of the transgenic lines (Figure 19).  
	   	   	  
	  





The Eph Receptor Tyrosine Kinase vab-1 may function in AIY axon outgrowth 
 
If efn-4 expression in the hypodermal tissue is required for axon outgrowth, then it suggests 
that a receptor is required on the AIY neuron to transduce the axon growth signal. We 
decided to take a look at the Eph receptor vab-1 as a possible candidate receptor to efn-4. 
If vab-1 is indeed the only receptor for efn-4 then we ought to see similar phenotypes to 
those seen in efn-4 including aberrant AIY interneuron outgrowth. vab-1(e2027) mutations  
display axonal outgrowth defects in the AIY neurons, but at a much lower level than efn-4. 
vab-1(e2027) nematodes display ~15% penetrance of aberrant axonal outgrowth suggesting 






Figure 20. AIY interneuron axon outgrowth defects in Eph receptor vab-1 mutant and ephrin ligand efn-4 
mutant animals. The sole Eph receptor vab-1(e2027) mutant animals display AIY interneuron outgrowth defects 
at approximately 15% (N=50). The outgrowth defects observed in vab-1(e2027) mutant animals does not 




When looking at the sole Eph receptor of C. elegans, vab-1 mutations in this gene cause 
highly penetrant gross head morphology defects. vab-1(e2027) mutant nematodes have an 
extreme “head-notch” phenotype that appears as a “gloved-head” (Figure 21). efn-4(-/-) and 
vab-1(-/-) double mutants exhibit synergistic lethality during embryogenesis making double 
mutants for efn-4 ligand and vab-1 receptor difficult to assay (Chin-Sang et al., 2002). 
 
 
	   	   	  
	  






Figure 21. Body morphology defects in efn-4, ephrin ligand and vab-1, Eph receptor mutants compared to wild 
type C. elegans body morphology. Eph receptor; vab-1(e2027) mutant nematodes display a severe “notched-
head” phenotype with extreme head indentations and “glove-like” heads. Ephrin ligand, efn-4 mutant animals 
present with a “bulged-tail” phenotype exhibiting with protruding bulbous tail body morphology. See wild type 
C. elegans body morphology for reference (WormAtlas).   
 
 
In the efn-4(bx80) mutant a “bulged” tail morphology manifests as a consequence of defects 
in ventral cleft enclosure during embryogenesis. If the efn-4(bx80) embryo survives 
embryogenesis the adult may display a bulging tail. When looking at a plate of efn-4(bx80) 
mutant nematodes the morphology of the tails appear as pseudo male sexual morphology. 
The “bulged” tail phenotype is modestly penetrant arising in approximately 30% of efn-
4(bx80) worms. (Figure 21). The Eph receptor vab-1 displays morphological defects in the 
tail with variable penetrance. vab-1 mutants displays a highly penetrant “head-notch” defect 
as does the canonical ligand efn-1, however, efn-4 mutants do not display this “head-notch” 
defects. So it is possible that efn-4 and vab-1 act together in the development of body 
morphology and/or throughout neurodevelopment but it is likely that efn-4 can also signal 
via one or more other receptors. 
 
During the course of our studies, we noticed that vab-1(e2027) mutants show an interesting 
phenotype not observed in efn-4(bx80) mutants in the AIY interneurons. AIYL/R axons 
project from the cell bodies on the dorsal side and meet at the central plexus before 
wrapping around to converge on the ventral side in synaptic junctions with their contralateral 
partner. In vab-1(e2027) mutants the AIY axons do not meet at the central plexus before 
wrapping around to meet their contralateral partner on the ventral side with nearly absolute 
penetrance (~50% penetrance) (Figure 22). VAB-1 has been shown to bind to EFN-4 albeit 
weakly and synergistic interactions between vab-1 and efn-4 point to an independent role 
for efn-4 from the sole Eph receptor vab-1 (Chin-Sang et al., 2002; Wang et al., 1999).  
 
 
	   	   	  
	  






Figure 22. Aberrant central plexus meeting in mutant EphR vab-1(e2027). The AIY interneurons of EphR vab-
1(e2027) exhibit an aberrant central plexus meeting. In a wild type AIY morphology the AIYL/R axonal 
projection extend from the dorsal cell bodies and meet at a central plexus before projecting to the ventral side 
to form a gap junction with their contralateral partner. This AIY aberrant central plexus meeting is unique to the 
EphR vab-1(e2027). Aberrant central plexus meeting in mgIs18otIs76vab-1(e2027) mutant nematode is highly 
penetrant at 50% aberrant central plexus meeting (asterisk indicates significant phenotype). 
 
 
mgIs18otIs76vab-1(e2027) mutant nematodes exhibit a highly penetrant defect the central 
plexus of the AIY interneurons (Figure 23). The AIYL/R axon projections ought to extend out 
from the dorsal cell bodies and meet at a central plexus before wrapping around the pharynx 
and meeting their contralateral partner on the ventral side (Figure 22). However, in vab-
1(e2027) mutant animals this fails to occur in approximately 50% of animals scored (Figure 
23). In conclusion it may be that vab-1 is required as a guidance cue to draw the two 








	   	   	  
	  






Figure 23. Eph receptor mutants exhibit defects in the central plexus of AIY interneurons. Null mutation of the 
vab-1(e2027) gene leads to a highly penetrant aberrant central plexus meeting phenotype where the AIYL/R 
axons fail to meet at the common central plexus. 50% of mgIs18otIs76vab-1(e2027) null for the Eph receptor 
vab-1 display this phenotype.   
 
 
A possible candidate-binding partner to ephrin EFN-4 is the LAD-2 L1 cell adhesion 
molecule (L1CAM) (Wang et al. 2008). Biochemical characterization of the interaction 
between EFN-4 and LAD-2 is discussed in Chapter 3: Biochemical Characterization of EFN-
4 Protein-Protein Interactions via Biolayer Interferometry. In the nematode double mutant of 
efn-4(bx80) and lad-2(tm3056) axon outgrowth defects observed are significantly different 







	   	   	  
	  






Figure 24. lad-2 L1CAM, efn-4 double mutant animals exhibit axon outgrowth defects. lad-2 efn-4 double 
mutants display axon outgrowth defects that are statistically significant from efn-4(bx80) single mutant alone. 
~35% aberrant outgrowth for lad-2(tm3056)efn-4(bx80) double mutants compared to efn-4(bx80) single mutant 
animals ~50% penetrant axon outgrowth defects. 
 
 
Taken together it may be that efn-4 acts in concert with another molecule and vab-1 to 
effect mechanistic action. Determining what this key player is in the model for efn-4 
mediation of neuronal development, adult morphology, and embryonic development is an 






















	   	   	  
	  







BIOCHEMICAL CHARACTERIZATION OF EFN-4 PROTEIN-PROTEIN 





































	   	   	  
	  






Previous findings suggest that EFN-4 is divergent and works redundantly or in parallel with 
VAB-1 Eph receptor tyrosine kinase (Chin-Sang et al., 2002). efn-4 vab-1 double mutants 
exhibit synergistic lethality suggestive of independent pathways (Chin-Sang et al., 2002). We 
propose to investigate a novel pathway whereby EFN-4 acts with an undisclosed binding 
partner to mediate nervous system development. Via biolayer interferometry (BLI) technique 
we seek to probe the protein-protein interactions between EFN-4 and its candidate-binding 
partner the L1 cell adhesion molecule (L1CAM) LAD-2 (Lihsia Chen, personal 
communication). In humans mutations in the L1 cell adhesion molecule (L1CAM) X-linked L1 
gene may lead to the neurological disorder CRASH (corpus callosum hypoplasis, 
retardation, adducted thumbs, spastic paraplegia, and hydrocephalus).  
 
L1 cell adhesion molecules include L1, NrCAM, neurofascin, and CHL1 (Kenwrick et al., 
2000). L1CAMs have been implicated in the semaphorin pathway to mediate axon guidance 
(Wang et al., 2008; Castellani et al., 2000). Semaphorins are capable of directing both 
attractant and repellant signals to the developing axon. Transmembrane semaphorin 
signaling is received by the plexin receptor on the recipient cell, which transduces a signal to 
the internal environment resulting in actin cytoskeletal rearrangement through collapsin 
response mediator protein and Rac GTPases. (Kruger et al., 2005). Furthermore, the L1CAM 
LAD-1/SAX-7 protein was shown to play a role in maintaining neuronal positioning in C. 
elegans (Sasakura et al., 2005; Wang et al., 2005). Axon navigation of the SDQL neurons in 
C. elegans is regulated via LAD-2, which mediates the interaction between the secreted 
MAB-20/Sema2 and its plexin receptor PLX-2 (Wang et al., 2008).   
 
Protein-protein interactions between the canonical Eph receptor VAB-1 and the ephrin 
ligands EFN-1 and EFN-4 were probed using biolayer interferometry (BLI). The L1 cell 
adhesion molecule (L1CAM) LAD-2 was investigated using BLI as a novel binding partner to 
the non-canonical ligand EFN-4. Biolayer interferometry (BLI) is an optical biosensing 
technique similar to surface plasmon resonance (SPR) in that it measures surface changes 
via wavelength deflection alterations that reflect changes in molecule association and 
dissociation from the surface. Anti-human-IgG capture biosensors (AHC) were used that 
contain a proprietary “biolayer” at the tip of a fiber optic sensor. The AHC sensor binds 
specifically to the human fragmented crystalline (Fc) region of our ephrin-Fc tagged proteins. 
White light passes down the fiber optic biosensor and reflects from the biolayer reference 
point. The ForteBio Octet instrument is equipped with a photo-detector that measures the 
interference pattern at the biolayer of the reflected light and commutes the change as a 
nanometer (nm) shift. Alterations in the biolayer at the biosensor tip are read as BLI 
sensorgrams where a positive nm shift is indicative of an association or binding of a 
molecule to the end of the biosensor. A negative nm shift indicates dissociation of a 
molecule from the end of the biosensor. The EFN-1 and EFN-4 ligand proteins were 
specifically engineered as Fc fusion proteins to enable “loading” of the proteins onto the tip 
of the AHC biosensor. Attachment of the ligand EFN-1 and EFN-4 proteins permitted 
subsequent interference measurements in nm shifts of analyte proteins “associating” and 
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“dissociating” from the biolayer and may be inferred as protein-protein interactions between 
the ligand and analyte measured. (Scott, I.M. et al., 2010; Salerno, J.C. et al., 2014, 
McMurry, J.L. et al., 2011; Wilson, J.L. et al., 2010)  
 
Proteins proposed to interact with EFN-4 were the sole C. elegans Eph receptor VAB-1 and 
the L1 cell adhesion molecule LAD-2 (Lihsia Chen, personal communication). RIG-3 served 
as an immunoglobulin (Ig) domain control to assess specificity of binding between EFN-4 
and LAD-2. RIG-3 belongs to the Ig superfamily (Figure 25) and serves as a non-specific 
control for EFN-4 binding to LAD-2 (Kavita et al., 2011). EFN-1 is known to interact with 
VAB-1 and serves as a “proof-of-principle” control in the biolayer interferometry experiments 







A. B. C. D. 
 
 
Figure 25. Schematic of proteins used in BLI experiment.  A. EFN-4 ephrin ligand composed of a 
glycosylphosphatidylInositol (GPI) anchor and a receptor-binding domain (RBD). B. VAB-1 Eph receptor 
composed of a receptor tyrosine kinase (RTK) domain, fibronectin type III (FNIII) domain, immunoglobulin (Ig) 
domain, and a ligand binding domain (LBD).  C. LAD-2 L1CAM hypothesized binding partner of EFN-4 
composed of six Ig domain repeats and a FNIII region juxtaposed to the transmembrane domain. D. RIG-3 Ig 








	   	   	  
	  




MATERIALS AND METHODS 
 
EFN-Fc ligand plasmid construction  
 
EFN-1∆SecΔGPI::Fc::SecTagA::MycHis and EFN-4∆Sec∆GPI::Fc::SecTagA::MycHis 
plasmids were constructed using the Gibson cloning assembly kit (New England 
BioLabs®Inc.). Gibson cloning works via an isothermal reaction where all the component parts 
are place in a single isothermal reaction vial. The Gibson single-reaction cloning strategy 
works by assembling multiple overlapping DNA molecules by the concerted action of a 5’ 






Figure 26.  Gibson cloning strategy. The component Gibson fragments and vector are combined in a single 
isothermal reaction vial (Gibson et al., 2009). 
 
 
Primers were designed with a vector (pSecTagA) overlapping region and insert (EFN) 
overlapping region: 
   
insert: EFN-1 (pLC708 (pcDNA3.1hibB+efn-1(myc)) 
vector: pSecTagA (pMH180) 
Forward primer: AGGCGCGCCGTACGAAATCCCCTAGTGGAACGATATG  
Reverse primer: GATCTTCccGAATTCTGCAAGcttCGACAAAACTCACACA  
 
insert: EFN-4 (pMH828 (punc-119::efn-4)) 
vector: pSecTagA (pMH180) 
Forward primer: AGGCGCGCCGTACGAAGcttAGACGAGCACATTGTCTAC  
Reverse primer: AAAATCCTTGGAATATTtAAGcttCGACAAAACTCACACA  
 
	   	   	  
	  






Figure 27. pSecTag A (Invitrogen) Mammalian expression vector used in construction of EFN ligand Fc tagged 
protein products for expression in HEK293T cells. pMH180 (Fc::pSecTagA::MycHis) in house plasmid vector 



















Step 2 Final 
Elongation 
Final Hold 
98°C 30sec Denaturation 98°C 10sec 72°C 7min 
30sec 
4°C ∞ 
Annealing  56°C 15sec 
















Step 2 Final 
Elongation 
Final Hold 
98°C 30sec Denaturation 98°C 10sec 72°C 7min 
30sec 
4°C ∞ 
Annealing  43°C 15sec 
Elongation  72°C 45sec 
Repeat 30X 
 
The linearized vector was subsequently generated via restriction enzyme digestion of 
pMH180 at the HindIII sites using the HindIII-HF restriction enzyme (New England 
BioLabs®Inc.) and CutSmart buffer (NEB®). The Gibson reaction was set up on ice by 
combining the respective EFN fragments inserts plus pSecTagA (pMH180) vector (3 insert: 1 
vector ratio), Gibson assembly master mix (2X) (NEB®) into a single reaction vial for each 
respective plasmid constructs and subsequently incubated in the thermocycler at 50°C for 
15 minutes. The plasmids were then transformed into NEB® chemically competent cellsand 
grown overnight on LB-AmpR (Ampicillin) plates. Plasmid identity was confirmed via 
restriction digestion. See Supplemental Data for complete sequence information.  
5/28/14 1:08 PMpSecTag A Sequence and Map
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Cell Culture  
 
HEK293T cells were culture in Dulbecco’s Modified Eagle’s Medium (DMEM) (caisson 
Laboratories Inc., North Logan, UT, USA) supplemented with 10% ultra-low IgG Fetal Bovine 
Serium (FBS) (GemCell™ U.S. Origin Fetal Bovine Serum, GEMINI Bio-Products), L-





Ephrin plasmids (efn-1::Fc::mychis and efn-4::Fc::mychis), EphR plasmid (vab-1::APtag2), 
the hypothesized efn-4 binding partner LAD-2 plasmid (lad-2::APtag2), and internal control 
(Fc::mychis (pSecTagA)) were transfected in HEK293T cells using Lipofectamine® 2000 
Transfection Reagent (invitrogen™, Life Technologies, Carlsbad, CA, USA). Lipofectamine® 
2000 Transfection Reagent was diluted to a ratio of 1:25 with Opti-MEM® (1X) Reduced 
Serum Medium (gibco® Life Technologies Corporation, Grand Island, NY, USA). All DNA 
was diluted with Opti-MEM® to a final concentration of 10ng/μl. Diluted Lipofectamine® 
was added to each transfection tube containing diluted DNA and allowed to incubate at 
room temperature for 5 minutes. Culture media was aspirated off the HEK293T cells and the 
cells were subsequently washed with ample amounts of PBS (caisson Laboratories Inc.). 
After incubation the Nucleic acid-Lipofectamine® 2000 complexes were added directly to 
cells containing Dulbecco’s Modified Eagle’s Medium (DMEM) culture medium (caisson 
Laboratories Inc., North Logan, UT, USA) with reduced FBS at 2.5% ultra-low IgG Fetal 
Bovine Serum (FBS) (GemCell™ U.S. Origin Fetal Bovine Serum, GEMINI Bio-Products), and 
supplemented with L-Glutamine (caisson Laboratories Inc.), and 1x Penicillin-Streptomycin 
(caisson Laboratories Inc.). Transfection plates were incubated at 37°C for a total of 48 
hours. Supernatants were harvested directly from the transfection plates.  
 
BLI (Biolayer Interferometry) 
 
BLI (biolayer interferometry) measurements were made on the FortéBio (Menlo Park, CA, US) 
Octet -QK biosensor using anti-hIgG Fc capture (AHC) biosensors (FortéBio, Inc.). Assays 
were performed in 96-well micro-plates at 25°C. All volumes were 200μl. Initial conditioning 
of the AHC biosensors was performed in Opti-MEM® (1X) Reduced Serum Medium (gibco® 
Life Technologies Corporation, Grand Island, NY, USA). Conditioning of AHC biosensor was 
run for a period of 3 minutes before the loading stage. Ephrin ligands with an Fc tag were 
loaded onto the AHC biosensors for 60 minutes. All subsequent well solutions were pipette-
loaded manually 5 minutes before the sample measurement to ensure sample evaporation 
did not occur. After loading of the ephrin ligands, a baseline was established in Opti-MEM 
for 15 minutes prior to a 60-minute analyte association phase. Dissociation was 
subsequently measured in Opti-MEM for 60 minutes.  
 
Dynabeads® Protein-G Purification of Fc tagged ephrin proteins  
 
Dynabeads® Protein G (Life Technologies™ Novex®) were used to collect a single fraction of 
purified mature extra-cellular domain Fc-tagged ephrin products from a mammalian system 
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HEK293T cells via pH shift chromatography. Protein G Dynabeads were added to EFN-
1::Fc, EFN-4::Fc supernatant suspensions harvested from transiently transfected HEK293T 
transiently transfected cells and gently rocked for 1-2 hours at room temperature. Impurities 
from the surrounds of the Dynabeads were washed in wash buffer (PBS-T pH7.4) via 
tumbling (3x). Proteins were eluted via pH shift of bound Fc tagged proteins with elution 
buffer (triethylamine (Et3N, pH 10) drop-wise into 50μl of 1M Tris-HCl (pH 7.2).   
 
Co-immunoprecipitation of EFN-4 interacting with LAD-2 L1CAM and EFN-1 
interacting with VAB-1 
 
HEK293T cells were transiently transfected with a non-lipid polymer MegaTran1.0 (OriGene) 
transfection reagent. MegaTran::DNA ratio of 2:1 (empirically derived ratio, data not shown) 
complexes were prepared immediately prior to transfection with the following plasmids: vab-
1::APtag2, lad-2::APtag2, APtag5, rig-3::APtag5::mychis, efn-1::Fc::mychis, efn-
4::Fc::mychis, and Fc::mychis. DNA was diluted with Opti-MEM® (Gibco®, Life 
Technologies). The MegaTran 1.0/DNA complexes (at ~ 1/10 total volume of culture dish) 
were added drop-wise to the HEK293T cells in Dulbecco’s Modified Eagle’s Medium 
(DMEM) culture medium (caisson Laboratories Inc., North Logan, UT, USA) with reduced 
FBS at 2.5% ultra-low IgG Fetal Bovine Serium (FBS) (Life Technologies), and supplemented 
with L-Glutamine (caisson Laboratories Inc.), and 1x Penicillin-Streptomycin (caisson 
Laboratories Inc.). The culture dishes were rocked gently to achieve even distribution of the 
complex and incubated at 37°C for 48 hours. The supernatants were harvested then 
supplemented with 1X HaltTM Protease Inhibitor Single-Use Cocktail (100X) (Pierce 
Biotechnology)*: AEBSF (1mM), Aprotinin (800nM), Bestatin (50μM), E64 (15μM), Leupeptin 
(20μM), Pepstatin A (10μM), EDTA* (5mM) to prevent degradation of proteins by endogenous 
proteases. 
Co-immunoprecipitation was carried out with magnetic Protein G Dynabeads® (Life 
Technologies). EFN-1::Fc, EFN-4::Fc, and Fc proteins (“prey”) supernatant harvest post-48 
transfection of HEK293T cells were incubated with Protein G Dynabeads O/N at 4° C. 
Unbound suspension was removed via magnet and re-suspended in 100mM Sodium 
Phosphate Buffer, pH 8.0, 0.02% Tween-20. and washed an additional 3X. Next, the bound 
Dynabead-ephrin-Fc complexes were incubated with VAB-1::PLAP, LAD-2::PLAP, RIG-
3::PLAP harvested proteins (“bait”) for approximately 2-3 hours at room temperature. The 
“bait” to “prey” Dynabead bound proteins were separated from the supernatant via pipetting 
off the supernatant from the magnet and resuspending in 50mM Sodium Phosphate, pH 8.0, 
300 mM NaCl, 0.01% Tween-20 and wash 1X. The protein “bait”/”prey” complexes were 
eluted by heating in 1X SDS-PAGE loading buffer at 70°C for 10 minutes. Co-
immunoprecipitated proteins were subsequently analyzed via western blotting. Pre-stained 
Page Ruler (Thermo Scientific) protein ladder served at the internal molecular weight 
standard. Anti-human PLAP primary antibody (rabbit polyclonal) and anti-rabbit-IgG HRP 
conjugated secondary were used to detect all PLAP tagged proteins (VAB-1::PLAP, LAD-
2::PLAP, and RIG-3::PLAP control). Mouse anti-cMyc primary antibody and anti-mouse-IgG 
HRP conjugated secondary antibodies were used to detect the Fc tagged proteins (EFN-
1::Fc-MycHis, EFN-4::Fc-MycHis and the control Fc-MycHis).  
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The Co-immunoprecipitation was also done in the reverse order with initial Protein G 
Dynabead® (Life Technologies) capture of PLAP tagged proteins via monoclonal anti-PLAP 
antibody incubation followed by incubation with Fc control to saturate any unoccupied 
binding sites on the Dynabead. “Prey” proteins with a PLAP tag: VAB-1::PLAP, LAD-
2::PLAP, and RIG-3::PLAP were added to each of the respective Dynabeads with anti-PLAP 
antibodies on the resin surface in suspsension and incubated for 1-2 hours at room 
temperature. Unbound protein was washed off the Dynabead via the magnet and the 
Dynabead capture PLAP tagged proteins were then incubated with “bait” proteins: EFN-
1::Fc::mychis, EFN-4::Fc::mychis, and Fc control. The “bait” to “prey” Dynabead bound 
proteins were separated from the supernatant via pipetting off the supernatant from the 
magnet and resuspending in 50mM Sodium Phosphate, pH 8.0, 300 mM NaCl, 0.01% 
Tween-20 and wash 1X. The protein “bait”/”prey” complexes were eluted via the 
thermocycler at 70°C for 10 minutes. Western blot analysis was carried out as described 
above.  
 
RTG-2 Trout Cell Transient Transfection and Cell Culture 
 
RTG-2 cells (ATCC) derived from mixed testis and ovary tissue of Oncorhynchus mykiss 
(rainbow trout) were utilized for C. elegans protein production at temperatures suitable for C. 
elegans proteins. RTG-2 cells were maintained in a sterile incubate at 22°C pulsed daily with 
CO2 for ten minutes to maintain cell culture atmospheric conditions. The RTG-2 cells were 
cultured in Earle’s Minimum Essential Medium (EMEM) [+] Earl’s Salts [+] L-Glutamine 
(Caisson Labs), supplemented with 250mM HEPES pH7.4, 10% Fetal Bovine Serum (Fetal 
Plex™, Gemini Bio-Products), and 1X Penicillin-Streptomycin (Life Technologies) to make a 
complete growth medium for the RTG-2 cells.   
 
Sub-culturing of RTG-2 cells were carried out as follows, T-25 (25cm2) angled culture flasks 
were used with approximately 3mL of EMEM complete growth medium with media renewal 
once per week. To dissociate the culture vessel of RTG-2 cells the old culture medium was 
aspirated off and discarded and the cell layer briefly rinsed with cold PBS to remove traces 
of trypsin inhibitors. Then 0.5-1mL of 0.25% (w/v) trypsin- 0.03% EDTA solution was added 
and incubated for 5-10 minutes or until the cell layer dispersed. The trypsin-EDTA solution 
was quenched with ~3mL of EMEM complete growth medium and aspirated up-and-down 
with gentle pipetting. Appropriate aliquots in new T-25 dishes to establish new culture 
vessels was done and the cultures incubated at 22°C. (R. Ian Freshney, 2005)  
 
Transient transfection of RTG-2 cells was carried out via formation of non-lipid polymer 
complexes using MegaTran 1.0 (OriGene) transfection reagent. Briefly DNA was diluted with 
OptiMEM and MegaTran 1.0 transfection reagent was added at a ratio 0f 3:1 MegaTran 1.0 
to DNA and vortexed for 30 seconds and allowed to sit for 10 minutes prior to addition to 
the RTG-2 cells to allow polymer DNA transfection complexes to form. After drop-wise 
addition of the DNA polymer complex to the RTG-2 cells the cells were incubated at 22°C 
for 48-hours until harvest of the protein products. Protein production was verified via 
western blot technique.  
 
	   	   	  
	  
	   	   	   	  	   	   	  	   52	  
	  
 
RESULTS AND CONCLUSIONS  
 
Investigating Protein-Protein Interactions through Biolayer Interferometry   
 
The efn-1 and efn-4 extracellular domain sequences were inserted into a plasmid with a 
human IgGκ secretion cassette and SV40 driver for transient transfection into HEK293T 
mammalian cells. Disulfide bond formation between Fc tags takes a monomeric form of the 
ephrin ligand to a dimeric form. In theory this enhances the binding affinity through assembly 
of a binding interface that is not present in the monomeric form (Pabbisetty et al., 2007). The 
dimeric ephrin ligands were presented to an anti-human-IgG biosensor probe in the initial 
“loading” phase of the biolayer interferometry (BLI) assay. Figure 28 shows the nanometer 





Figure 28. EFN-1::Fc and EFN-4::Fc can bind to anti-human-IgG (AHC) BLI capture probes. The EFN-1 and 
EFN-4 extracellular domain proteins tagged with fragmented crystalline (Fc) tag bind to anti-human-IgG 
capture probes (AHC). A nanometer shift of ~7nm indicates that the capture probe is binding the ligand 
proteins. Wavelength deflection from the end of the probe tip indicates that the biolayer of the biosensor in 
changing due to attachment of protein. 
 
 
Anti-human-IgG Fc capture (AHC) biosensors (FortéBio, Inc.) were used to attach the Fc 
tagged EFN protein products to the end of the biosensor probe tip. Loading of EFN-1::Fc 
protein product harvested from HEK293T cells is seen in the BLI graph by the ~ 7nm shift. 
Likewise the EFN-4::Fc ligand loaded onto the AHC biosensor probe (Figure 28).  
 
Collaboration with Lihsia Chen (University of Minnesota) presented us with an opportunity to 
explore an interaction between the L1 cell adhesion molecule (L1CAM) and EFN-4. LAD-
2/L1CAM functions as a co-receptor to secure MAB-20/Semaphorin-2A coupling to the 
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PLX-2/plexin receptor (Wang et al., 2008). EFN-4 has been suggested to act in a linear 
genetic pathway with MAB-20 (Ikegami et al., 2004; Nakao et al., 2007). We propose that 
LAD-2 may be acting as a receptor to EFN-4. This interaction may act to couple EFN-4 to 
MAB-20 or another receptor, similarly enhancing or strengthening an interaction as in MAB-
20 and PLX-2 interaction. Alternatively, the interaction may be solely between EFN-4 and 
LAD-2 to regulate axon guidance/outgrowth, although the exact mechanisms remain to be 
elucidated. In addition, there is compelling genetic data to support that L1 Cell Adhesion 
Molecule (L1CAM) LAD-2 functions via the non-canonical ephrin EFN-4 (Lihsia Chen, 
personal communication).  
 
We aimed to use BLI to characterize the biochemical interactions of EFN-1 and EFN-4 to 
their proposed binding partners: the canonical EphR, VAB-1 and the L1CAM LAD-2. The 
“association” phase was followed by the series of phase: probe conditioning, biosensor 




Figure 29. BLI sensogram of EFN-1 and EFN-4 ephrin ligands interacting with the canonical VAB-1 Eph 
receptor and the novel LAD-2 L1 Cell Adhesion Molecule binding partner. Panel A. depicts the association 
phase of EFN-1 and EFN-4 binding to the proposed receptors: VAB-1 and LAD-2. EFN-4 binds to LAD-2 with 
the greatest nm shift (~2.7nm). Panel B. depicts the dissociation phase of each EFN-1 and EFN-4 bound to 
VAB-1 and LAD-2 separately. Linear dissociation in panel B is consistent with high-affinity interactions. BLI 
traces were referenced to Fc using the Octet software and rendered in GraphPad Prism software (GraphPad 
Prism Software, Inc.). Fc control did not bind to VAB-1 nor did it bind to LAD-2.   
 
 
Association between the ligand present on the probe tip and the analyte to be tested is seen 
as a nanometer shift in wavelength deflection from the end of the biosensor indicative of 
bound analyte to ligand on the probe. We found that EFN-1 and VAB-1 displayed 
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appreciable association kinetics as expected (Figure 29). In addition, we also saw binding 
between EFN-4 and VAB-1. Our data agrees with previously published in vivo and in vitro 
evidence that EFN-4 can bind to VAB-1 (Wang et al., 1999).  
 
We also observed a binding interaction between EFN-4 and LAD-2. The shape of the 
association phase sensogram was unique and the nanometer shift was significant (Figure 
29). The dissociation phase of the ephrin proteins to the bound EphR VAB-1 and L1CAM 
LAD-2 displayed essentially no dissociation, which is consistent with a tight ligand-receptor 
interaction. The ephrin ligands were presented in theory as dimers due to the nature of the 
Fc fragments binding in pairs. Dimeric presentation of ephrin ligands as opposed to 
monomeric ephrin presentation enhances the binding affinity and may explain the apparent 
lack of dissociation in the BLI sensogram (Pabbisetty et al., 2007). The association and 
dissociation phases represent the interaction between EFN-4 and LAD-2 as a qualitative 
“fast-on” on and “slow-off”, high-affinity protein-protein interaction. Our data support a 
biophysical interaction between EFN-4 and the L1CAM LAD-2. Furthermore this discovery of 
a novel physical interaction between LAD-2 and EFN-4 may provide insight into the 
mechanisms that regulate axon outgrowth.  
 
Ephrin ligand protein production from HEK293T cells was confirmed and detected using 
western blotting. Ephrin ligands: EFN-1::Fc::mychis and EFN-4::Fc::mychis and the Fc 
control were detectable in both the supernatant harvest from the HEK293T cells (Figure 31) 
and the cell lysates (Figure 30) 48-hours post-transfection.  
 
The secreted form of LAD-2::APtag2 was detectable via colorimetric detection using BM 
purple (Roche Life Science) (Figure 32). VAB-1::APtag5::mychis was detectable in the cell 
lysate sample western blot (Figure 30). Both VAB-1 and LAD-2 had colorimetric turnover of 
the substrate BM purple in the supernatant samples (Figure 32). Detection of the proteins in 
the secreted form is important for these are the samples loaded into the BLI wells. BM 
purple substrate turnover is an indicator that the PLAP (placental alkaline phosphatase) 
activity is present. LAD-2::AP and VAB-1::AP contain the PLAP tag and from turnover of the 
BM purple substrate it may be deduced that the proteins of interest are also present (Figure 
32). Note that the endogenous alkaline phosphatase of the supernatant samples were heat 
denatured at 65°C for 30 minutes prior to the addition of BM purple substrate (see methods). 
PLAP tag is heat stable at 65°C and with the initial heat denaturation step prior to substrate 
turnover one may ensure that only the heat stable PLAP fusion proteins are producing BM 
purple substrate turnover. The Ig domain control RIG-3::APtag5::mychis was detectable in 
both the supernatant and cell lysate samples via traditional western blotting technique with 
the primary antibody anti-cmyc (produced in mouse) and the secondary antibody anti-
mouse-IgG HRP conjugated (Figure 34). 
 
	   	   	  
	  






Figure 30. Western blot of HEK293T transfected cell lysates for Fc control, EFN-1, EFN-4, PLAP control and 
VAB-1 proteins. HEK293T cells were transfected with the following plasmids: pSecTagA::Fc::MycHis, efn-
1::Fc::MycHis, efn-4::Fc::MycHis, APtag5::MycHis, vab-1::APtag5::MycHis and a SHAM control was included 
to produce the desired protein products. The western blot was probed with primary antibody anti-cMyc, 
produced in mouse and the secondary antibody anti-IgG to mouse produced in rabbit. Fc control protein size 
~25-30kDa. EFN-1::Fc protein size ~ 54kDa. EFN-4::Fc protein size ~ 67kDa. PLAP protein ~ 60kDa. VAB-








	   	   	  
	  






Figure 31. Western blot of HEK293T transfected supernatants for Fc control, EFN-1, EFN-4, PLAP control and 
VAB-1 proteins. HEK293T cells were transfected with the following plasmids: pSecTagA::Fc, efn-1::Fc, efn-
4::Fc, APtag5, vab-1::APtag5::mychis and a SHAM control was included to produce the desired secreted 
protein products. The western blot was probed with primary antibody anti-cmyc, produced in mouse and the 
secondary antibody anti-IgG to mouse produced in rabbit. Fc control protein size ~25-30kDa. EFN-1::Fc 







Figure 32. AP turnover assay: a quantitative assay of the alkaline phosphatase activity of AP-fusion proteins. 
Enzymatic de-phosphorylation of the substrate BM Purple (Roche) by alkaline phosphatase produces a purple 
colored precipitate. Heat inactivation of endogenous alkaline phosphatase prior to addition of BM Purple and 
NTMP buffer. 200μl supernatant of HEK293T cells transiently transfected with pertinent plasmid constructs 
added to 250μl NTMP and 250μl BM Purple substrate.  A. vab-1::APtag2 B. APtag5 C. vab-1::APtag5 D. lad-
2::APtag2 E. efn-4::APtag2 F. HEK293T mock transient transfection. 
 
 
An Fc (Fragmented Crystalline) region control for ligand binding to receptor was 
implemented in the biolayer interferometry assays and used to subtract out baseline drift. 
The Fc control was transfected and harvested in parallel with the variable proteins (EFN-
1::Fc and EFN-4::Fc) and loaded onto the biosensor probe as expected. No signification 
interaction (shift in nanometer) was seen between the Fc control and the tested analyte 
receptors. To further control for the biophysical assay an additional protein, RIG-3, was 
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assayed to control for the binding specificity between EFN-4 extracellular domain and LAD-
2 extracellular domain. RIG-3 is an immunoglobulin super family protein with an extracellular 
domain consisting of two Ig (Immunoglobulin) domains and a single FNIII (Fibronectin type 
III) domain (Babu et al., 2011). No appreciable binding between any of the ephrin ligands, 
EFN-1 or EFN-4 with RIG-3 control was observed (Figure 33). Hence, the biophysical 
interaction between EFN-1 and VAB-1 and the interaction between EFN-4 and LAD-2 are 





Figure 33. EFN-4 does not bind to the Ig domain control RIG-3 protein. Depicted are the association and 
dissociation phases of EFN-4 binding to LAD-2 and lack of EFN-4 binding to RIG-3. EFN-4 binds to LAD-2 with 




Western blotting of the RIG-3 control confirmed successful transient transfection and protein 
production in the HEK293T cells using the plasmid encoding RIG-3 (Figure 34). Protein 
production of RIG-3 and the control proteins APtag5 and Fc was robust. However 
production of LAD-2, VAB-1, EFN-1, and EFN-4 were minimal.  
 
To circumvent limited protein production in HEK293T cells an alternative cell line was 
introduced. We hypothesized that C. elegans proteins would be better manufactured at 
22°C, the normal culture temperature for C. elegans, rather than the 37°C cell culture 
temperature of HEK293T cells. RTG-2 trout cells were utilized for this hypothesis with 
standard transient transfection with MegaTran 1.0 transfection reagent (see Materials and 
Methods). RIG-3::APtag5 protein production as well as APtag5 control, LAD-2::APtag2, and 
VAB-1::APtag2 proteins were detectable in the supernatant samples post 48-hour 
transfection via colorimetric BM purple substrate turnover (Figure 35.) 
 
	   	   	  
	  






Figure 34. Western blot of RIG-3 Ig control. HEK293T cells were transfected with rig-3::APtag5::MycHis and a 
SHAM control was included to produce RIG-3 secreted protein. The western blot was probed with primary 
antibody anti-cmyc, produced in mouse and the secondary antibody anti-IgG to mouse produced in rabbit. 







Figure 35: AP turnover assay of RTG-2 trout transfected cells. BM purple (Roche) substrate enzymatic turnover 
by AP-fusion proteins. RTG-2 trout cells were transiently transfected with the following plasmids: APtag5, rig-
3::APtag5, lad-2::APtag2, and vab-1::APtag2 to produce the desired secreted C. elegans protein products at 
22°C. Endogenous alkaline phosphatases were heat inactivation prior to addition of BM Purple and NTMP 
buffer (100mM Tris-HCl, pH 9.5, 100mM NaCl, 50 mM MgCl2, 0.1% Tween-20). Colorimetric (purple/dark) 
indicate enzymatic activity and the presence of an AP-fusion protein. 
 
 
Co-immunoprecipitation Experiments to Probe EFN-4 Protein-Protein Interactions 
 
To support our BLI results, we also attempted to co-immunoprecipitate the candidate 
binding protein LAD-2/L1CAM and EFN-4. We also wanted to investigate further into the 
binding between EFN-4 and VAB-1 as this interaction in the literature is posited to be a 
weak interaction (Wang et al., 1999; Chin-Sang et al., 2002). Co-immunoprecipitation (Co-IP) 
experiments were carried out with Protein G Dynabeads® (Life Technologies) as 
“bait”/”prey” assays. The ephrin ligands, EFN-1 and EFN-4 served as the “bait” bound to the 
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Protein G Dynabead and allowed to bind to the “prey”, either the EphR VAB-1 or the L1CAM 
LAD-2 initially. To test whether VAB-1 or LAD-2 bound to the ligands, we eluted the “bait” 
and “prey” combination and detected the “prey” protein via Western blot: the “prey”, in this 
case being VAB-1::AP or LAD-2::AP (Figure 36). Detection of “prey” protein was nil in this 
set-up and may be due to the antibody used to detect human PLAP tag on the VAB-1::AP 
and LAD-2::AP proteins defective. A polyclonal anti-human-PLAP antibody was used but 
failed to display a band in a control western blot, despite the presence of ample AP protein.  
 
Reverse Co-IP was carried out where the “prey” was loaded onto the Protein G Dynabead 
by first attaching a monoclonal anti-PLAP antibody onto the Dynabead and then incubating 
with VAB-1::AP, LAD-2::AP, and the Ig control RIG-3::AP. In pilot assays, the monoclonal 
anti-PLAP was capable of significantly enriching for VAB-1::AP as detected via colorimetric 
assay. The Dynabead “prey” combinations were then incubated with the ephrin ligands EFN-
1 and EFN-4 as well as Fc control. Western blot detection post elution of proteins from the 
Dynabeads revealed the presence of ephrin ligands EFN-1 and EFN-4 indicating that the 
“bait” ligands bound to the “prey” receptors on the Dynabeads (Figure 37). However, Fc 
detection in all elution samples confounds the data. This may be due to binding of the Fc-
tagged proteins to unoccupied sites on the Protein G Dynabead rather than to the “prey” 


















	   	   	  
	  








Figure 36. Co-immunoprecipitation western blots of EFN-1, EFN-4 interacting with LAD-2 and VAB-1 with RIG-
3 control. Western blot of Dynabead elution products from initial capture of monoclonal anti-PLAP antibody on 
the Protein G Dynabead to then incubate the “prey” PLAP tagged proteins: RIG-3::PLAP, VAB-1::PLAP, and 
LAD-2::PLAP. Binding of “prey” was followed by capture of “bait” Fc-tagged proteins: Fc::mychis, EFN-
1::Fc::mychis, and EFN-4::Fc::mychis. Anti-cmyc primary (produced in mouse) and anti-mouse-IgG HRP 




	   	   	  
	  








Figure 37. Co-immunoprecipitation western blot of EFN-1, EFN-4 interacting with LAD-2 and VAB-1 with RIG-3 
control. Western blot of Dynabead elution products from initial capture “prey” Fc tagged proteins: Fc::mychis, 
EFN-1::Fc::mychis, and EFN-4::Fc::mychis onto Protein G Dynabeads and subsequent incubation with “bait” 
proteins: RIG-3::PLAP, VAB-1::PLAP, and LAD-2::PLAP. Anti-cmyc primary (produced in mouse) and anti-
mouse-IgG HRP conjugated secondary were used to detect Fc::mychis tagged proteins. Anti-humanPLAP 
(polyclonal, produced in rabbit) primary and anti-rabbit-IgG HRP conjugate secondary antibody were used to 























	   	   	  
	  













































	   	   	  
	  




EPH RECEPTORS AND EPHRINS IN CAENORHABDITIS ELEGANS 
 
To gain insight into the genetic and molecular mechanisms that govern neurodevelopment 
we investigated EphR-ephrins and the L1CAM LAD-2 molecules for their requirements in the 
AIY interneuron development in Caenorhabditis elegans. EphR-ephrins were focused on in 
our studies for (1) the importance of EphR-ephrin signaling in regulating numerous 
neurodevelopmental processes including neuronal cell migration, axon outgrowth and 
guidance, and refinement of neuronal connections (2) conservation of function and 
sequence homology between Caenorhabditis elegans and Homo sapiens (Flanagan and 
Vanderhaeghen, 1998).  
 
Axon outgrowth as mediated by ephrins is likely to be through direct cell-to-cell contact 
where the ephrin ligand anchored to the cellular membrane signals to a juxtaposed cell via 
contact with the Eph receptor (Flanagan and Vanderhaeghen, 1998; Himanen and Nikolov, 
2003). Alternatively, ephrin ligands are capable of being cleaved by metalloeproteases from 
a tethered-state to a free-state permitting signaling from a distant source. This is classically 
considered to function as Eph receptor mediated repulsion by ADAM (A Disintegrin and 
Metalloeprotease) cleavage of the tethered ligand on the juxtaposed cell initiating release 
from the EphR-ephrin complex and subsequent cellular repulsion (Janes et al. 2009; Hattori 
et al., 2000). The most widely accepted means of ephrin-EphR signaling is via direct cell-to-
cell contact although it remains a possibility that this mechanism of action may not be the 
exclusive manner in which ephrin signaling is effected. If we consider the juxtacrine signaling 
paradigm of EphR-ephrin signaling, then both the pharyngeal tissue and the hypodermis 
appeared to be a likely source of ephrin ligand expression to mediate axon outgrowth, as 
the pharyngeal cells are in close proximity to the AIY cell bodies during embryonic 
development (Worm Atlas).    
 
The data presented in this thesis suggest that the hypodermal cells are signaling to the AIY 
interneurons during embryogenesis in a direct cell-to-cell contact manner. EFN-4 is an 
ephrin-A GPI anchored ligand and is proposed to interact with a receptor on the AIY cell 
surface to regulate axon outgrowth. EFN-4 may interact directly with VAB-1 to mediate axon 
outgrowth, although our data indicates that at least one or more other receptors may be 
functioning in concert with VAB-1. Perhaps the L1CAM LAD-2 is a more likely interacting 
partner with EFN-4 (see Chapter 3) although our data to this point is inconclusive.   
 
It may be that VAB-1 signals from the neuronal substrate to surrounding ephrin-ligand 
bearing epithelial cells during embryogenesis to effect proper cell migration and regulate 
cell-adhesion and repulsion. To accomplish such signaling mechanisms the neuronal cells 
bearing the VAB-1 Eph receptor may receive a signaling cue from the epithelial cell and 
transduce the signal in a forward-signaling direction to the neuronal cell. Another possibility 
is that the ephrin ligand found on the epithelium may transduce a reverse-signal upon direct 
contact with the neuronal substrate. Both forward- and reverse-signaling mechanisms are 
possible to regulate neuronal and epithelial cell movement.  
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Biolayer interferometry data of EFN-4 and LAD-2 suggests a high-affinity interaction 
between EFN-4 and LAD-2. The biophysical data points to a mechanism whereby LAD-2 
and EFN-4 interact. It remains a possibility that LAD-2 is either a receptor for EFN-4 or acts 
as a co-receptor in a yet undisclosed molecular interaction to mediate axon outgrowth.  
 
The Eph receptor VAB-1 may have additional roles in shaping AIY neuron morphology  
 
The highly penetrant aberrant central plexus phenotype of vab-1(e2027) is striking in that AIY 
axonal projections appear to be repelled from the central plexus area. Whether this 
phenotype has any functional consequences is yet to be determined. To further test the 
hypothesis that vab-1 may act as a guidance cue to draw together the two bilaterally 
symmetric axons of the AIY interneurons at the central plexus, transgene expression assays 
could be used to assay whether VAB-1 is functioning cell autonomously in the AIY neurons, 
or non-cell autonomously in the surrounding tissue. A ttx-3 promoter could be used to 
express vab-1 in the AIY neurons alone. Alternatively, one could express vab-1 cDNA back 
into the pharynx and assay for rescue. If the pharynx would not work as a site of rescue, the 
central plexus is rich in neurons and possibly another neuronal type that meets at the central 
plexus could express vab-1 and this may rescue the aberrant central plexus meeting 
phenotype in a mutant background. If the expression of a vab-1 wild type cDNA in the AIY 
neurons alone did indeed rescue this AIY interneuron central plexus phenotype in a vab-
1(e2027) mutant background then it may be concluded that cell autonomous regulation of 
axon meeting at the central plexus is controlled, in part, by the VAB-1 Eph receptor.  
 
BIOCHEMICAL CHARACTERIZATION OF EFN-4 AND ITS CANDIDATE PROTEIN-
PROTEIN INTERACTIONS 
 
Dimeric ephrins formed through fusion with disulfide-linked Fc fragments enhances the 
binding affinity to EphR (Pabbisetty et al., 2007). Pabbisetty et al. showed that dimeric 
ephrins bind to their Eph receptor in a two-step process involving an initial monovalent 2:1 
binding followed by a divalent 2:2 binding that dramatically decreases the apparent 
dissociation rate constant. (Pabbisetty et al., 2007). Strong association with no appreciable 
dissociation seen in our BLI traces may indicate that EFN-1 and EFN-4 ligands are bivalently 
binding to their candidate proteins with increased avidity, dramatically decreasing the 
apparent dissociation rate.  Using an anti-humanIgG capture probe to the dimeric disulfide 
linked Fc fragment tagged ephrins we presented our ligands to EphR analyte in a dimeric 
fashion. Association kinetics revealed a “fast-on” ephrin/EphR interaction and a negligible 
dissociation rate for the bound Eph receptors to ephrin ligands in agreement with findings by 
Pabbisetty et al. Increase binding affinity is attributable to the avidity theory where multiple 
independent binding interactions between partners increase the apparent binding interaction 
strengthening the binding association (Pabbisetty, 2007). Ephrin ligands and their Eph 
receptors exhibit binding interfaces upon cluster formation with changes in binding affinities 
dependent on inter- verses intra- class and homo- verses hetero- cluster formation 
(Himanen & Nikolov, 2001, 2003, 2007; Qin et al., 2010; Pabbisetty et al., 2007; Seiradake et 
al., 2013). An interesting avenue for future research would be to elucidate the binding 
kinetics of different combinations of pre-clustered homo- and hetero- complexes of ephrin 
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ligands to proposed candidate receptors, albeit this research feat would certainly be 
technically involved.   
Our Fc tagged proteins are thought to take the ephrin ligand from a monomeric 
configuration to a dimeric one. In terms of binding models the interaction is taken from the 
single component of 1:1 Langmuir binding 𝐿 + 𝑅 ⇆ 𝐿𝑅  to a bivalent 2:1 model L! + 2𝑅   ⇆
𝐿!𝑅 + 𝑅   ⇆ 𝐿!𝑅!.   In a similar application, murine ephrin-B2 and human ephrin-A5 were 
expressed as Fc-fusion proteins in HEK293 cells and subjected to thrombin cleavage of the 
Fc tag.  Free Fc tags may be pulled down using Protein A beads. Removal of the Fc tag from 
the Fc fusion ephrin-B2 and ephrin-A5 followed by size exclusion chromatography on 
Superdex 200 (Amersham Biosciences) confirmed that the Fc-fusion ephrins are indeed 
dimeric whereas cleavage of the Fc tag resulted in monomeric ephrins. (Pabbisetty et al., 
2007) 
The BLI sensogram of EFN-4 interacting with LAD-2 (figure) shows near 0.3 nm shift in 
wavelength deflection from the biolayer and a characteristic trace exhibiting a unique rise 
shape and amplitude. Being that the BLI sensogram trace is different to that of EFN-1 and 
VAB-1 points towards a true biophysical interaction between EFN-4 and LAD-2. The 
negligible dissociation between EFN-4 and LAD-2 is consistent with a high-affinity 
interaction.  
Our findings suggest EFN-4 is a key player in cell-to-cell communications that guide AIY 
neuronal projections. EFN-4 binds with promiscuity to both the canonical VAB-1 Eph 
receptor in C. elegans and additionally to at least one other binding partner the L1CAM (L1 
Cell Adhesion Molecule) LAD-2. Whether there is cooperative binding between EFN-4, VAB-
1 and LAD-2 is not known and is a possible avenue for future research. Findings indicate 
that VAB-1 is co-expressed with SAX-3, the C. elegans ortholog of the Drosophila 
Roundabout (Robo), on a subset of neuroblasts possibly in a complex (Ghenea et al., 2005) 
Co-Immunoprecipitation assays of LAD-2 interaction with SLT-1, the SAX-3 ligand, and 
SAX-3 do not suggest that LAD-2 interacts with either of these proteins (Wang et al., 2008). 
Expression of LAD-2 & EFN-4  
 
LAD-2 displays a restricted expression pattern to just 14 neurons in C. elegans. Interestingly, 
some neurons having lad-2 expression and some axonal projections occur post-
embryonically. SDQL, SDQR, PLN, and ALN neuronal birth is post-embryonically and the 
SMD neurons, although embryonically derived, send axonal projections throughout all of the 
larval stages. (Wang et al., 2008)   
 
Late axonal migration in larval stages raises an intriguing aspect of neural plasticity later in 
development. Neurons sending axonal projections, which respond to the advent of 
environmental cues received in late stages of development, post-embryonically, represent a 
model of learning and plasticity later in life. This brings up the consideration of “nature” vs. 
“nurture” in neural plasticity paradigms. In C. elegans the neurons expressing lad-2 
characteristically have late-extending axons. This late-extending and “plastic” characteristic 
of these neurons may be contingent on the influx of environmental cues and the efflux of 
gene expression. For example, the SDQL, SDQR, PLN, and ALN neurons function in 
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hyperoxia avoidance (A. Chang et al., 2006). Furthermore, axon pathfinding is sensitive to 
levels of oxygen in a developing nervous system. Hypoxia (oxygen deprivation) leads to 
defects in axon pathfinding and neuronal migration in C. elegans. In humans oxygen 
deprivation during brain development leads to severe brain dysfunction. Axon pathfinding is 
sensitive to hypoxia at least in part through the hypoxia-inducible factor 1 transcription 
factor HIF-1-dependent regulation of the Eph receptor VAB-1. HIF-1 upregulates VAB-1 
expression in response to hypoxia in the embryo of C. elegans . (Pocock and Hobert, 2008) 
Whether this upregulation of VAB-1 occurs during the later stages of development is of 
question.  
 
The Eph receptor VAB-1 binds to EFN-4, is cryptically controlled via EFN-2 and EFN-3, and 
canonically binds to EFN-1 (Chin-Sang et al., 2002). For the purpose of this research, finding 
that EFN-4 and LAD-2 interact biophysically it will be interesting to explore the possibility of 
EFN-4 and LAD-2 function in late stage neuronal plasticity in response to environmental 
stimuli such as oxygen levels. If LAD-2 and EFN-4 do indeed function together then they 
may hypothetically function to regulate plasticity of neurons in response to oxygen levels 
possibly through VAB-1. Since VAB-1 expression in the advent of oxygen changes is 
dependent on regulation by HIF-1 VAB-1 in a sense may act as a capacitor for axon 
pathfinding whereby the relative levels of VAB-1 expression on the surface of the cell directly 
influences the cellular response to presented environmental guidance cues such as EFN-4 
and EFN-1, 2, and 3.  
 
EFN-4 may act independently of VAB-1 exhibiting unique phenotypes by binding 
promiscuously to another receptor other than VAB-1. LAD-2 and EFN-4 biophysically 
interact and this may be the pathway whereby EFN-4 exerts its functions to give rise to 
novel phenotypes independent of the canonical VAB-1 pathway.  
 
INTEGRATION OF THESIS RESEARCH  
 
Execution of voluntary movement is an integrative human capacity that dynamically requires 
response to environmental cues. This requires continuous integration and learning to acquire 
new motor skills. Descending fibres from cortical and subcortical motor areas coupled to 
feedback via afferent pathways in different spinal and supraspinal circuitries is an intricate 
system that gives us the ability to carry-out complex motor functions (Maier and Schwab, 
2006) Complex motor function such as dancing and creating art with media is a result of 
acquisition of learned skills that is only capable at the most fundamental level by laying 
down new neuronal connections and building upon neuronal circuitries already in place. 
Spinal cord injury (SCI) presents an unfortunate circumstance as the CNS lacks regenerative 
capacities and permanent neurological deficits result post- brain or spinal cord lesions. SCI 
interrupts such vital ascending and descending pathways and disrupts the proper 
innervation signals and may lead to severe motor dysfunction.  
 
Studies of the mechanism of EphR and ephrins have immense potential in regenerative 
medicine for areas of neuronal plasticity and nerve regeneration. The mechanisms of action 
that drive neurodevelopment during embryogenesis may shed light on factors of 
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neuroplasticity. Given the cells that communicate together during embryogenesis, the same 
signaling mechanisms could be implemented for re-innervation of severed nerves in an 
injured tissue. Spinal cord injury represents one such possible injury in need of neuro-
regenerative therapeutics and novel innervation technologies. Growth inhibitory factors and 
growth stimulatory factors will need to be considered when constructing a neuronal 
regeneration model. Inhibitors of neuronal outgrowth include members of axon guidance 
molecules (e.g. semaphorins, ephrins, netrins), prototypic myelin inhibitors (Nogo, MAG, and 
OMgp) and chondroitin sulfate proteoglycans (lecticans, NG2). Eph-ephrins already play a 
vital role in response to CNS response to injury. EphA3 is up regulated in astrocytes after 
spinal cord injury (SCI) in rats (Irizarry-Ramirez et al., 2005). If the properties of Eph-ephrin 
signaling may be harnessed, a more refined medical approach to CNS and PNS repair in 
response to injury may be implemented. The work presented in this Thesis approaches this 
understanding of Eph-ephrin signaling with the hopes that some of the findings may be 
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pMH833 (pelt-3::efn-4) à efn-4 cDNA driven by hypodermal promoter 
pMH853 (pmyo-2::efn-4) à efn-4 cDNA driven by pharyngeal promoter 
pMH999 (pmyo-3::efn-4) à efn-4 cDNA driven by body wall muscle promoter 
pCZ148 (genomic efn-4) à genomic efn-4  
pMH800 (pttx-3::efn-4) à efn-4 cDNA driven by AIY specific promoter 
pMH828 (punc-119::efn-4) à efn-4 cDNA driven by pan-neuronal promoter 
pMH180 (pSecTagA)  
pMH873 (EFN-1ECD::Fc fusion clone in pSecTagA) 
pMH874 (EFN-4ECD::Fc fusion clone in pSecTagA) 
pCZ1441 (VAB-1ECD::AP fusion clone in APtag2) 
pLC7141 (LAD-2ECD::AP fusion clone in APtag2) 
pLC7221 (RIG-3::AP fusion clone in APtag-5)  
 
1Lihsia Chen. University of Minnesota contributed reagents/plasmids. 
 
Transgenic Line Microinjection Mix 
 
mgIs18otIs76bx80 KenEx[pmyo3::efn-4 pmyo-3::mcherry] A2 at:  
plasmid [stock] vol. to add [final] 
pmyo-3::mcherry 75ng/μl 0.5μl 2ng/μl 
pmyo-3::efn-4 75ng/μl 0.5μl 2ng/μl 
pBSII 104ng/μl 8.5μl 45ng/μl 
H2O  10.5μl  
  20μl 50ng/μl 
 
mgIs18otIs76bx80 KenEx[pmyo3::efn-4 pmyo-3::mcherry] H2* at:  
mgIs18otIs76bx80 KenEx[pmyo3::efn-4 pmyo-3::mcherry] H3* at: 
mgIs18otIs76bx80 KenEx[pmyo3::efn-4 pmyo-3::mcherry] C2* at:  
*all injected with same microinjection mix 
plasmid [stock] vol. to add [final] 
pmyo-3::mcherry 75ng/μl 6.7μl 25ng/μl 
pmyo-3::efn-4 75ng/μl 2.7μl 10ng/μl 
pBSII 107ng/μl 2.8μl 15ng/μl 
H2O  7.8μl  






	   	   	  
	  




mgIs18 otIs76 bx80 KenEx(pCZ148 ttx-3::RFP) P1 at: 
mgIs18 otIs76 bx80 KenEx(pCZ148 ttx-3::RFP) P2 at: 
mgIs18 otIs76 bx80 KenEx(pCZ148 ttx-3::RFP) P3 at:  
*all injected with same microinjection mix 
plasmid [stock] vol. to add [final] 
pCZ148 300ng/μl 0.5μl 1ng/μl 
pttx-3::RFP 340ng/μl 2μl 25ng/μl 
pBSII 107ng/μl 4.5μl 24ng/μl 
H2O  13μl  
  20μl 50ng/μl 
 
 
   
mgIs18 otIs76 bx80 kenEx[pMH853 p-myo-2::mcherry] 1A at: 
mgIs18 otIs76 bx80 kenEx[pMH853 p-myo-2::mcherry] 3A at: 
mgIs18 otIs76 bx80 kenEx[pMH853 p-myo-2::mcherry] 2A at: 
mgIs18 otIs76 bx80 kenEx[pMH853 p-myo-2::mcherry] 3B at:  
*all injected with same microinjection mix 
plasmid [stock] vol. to add [final] 
pmyo-2::efn-4 
(pMH853) 
ng/μl μl 10ng/μl 
pmyo-2::mcherry  ng/μl μl 20ng/μl 
pBSII ng/μl μl 20ng/μl 
H2O  μl  




mgIs18 otIs76 bx80 kenEx[p-elt-3::efn-4 sur-5::GFP ttx-3::RFP] 7C at: 
mgIs18 otIs76 bx80 kenEx[p-elt-3::efn-4 sur-5::GFP ttx-3::RFP] 7A at: 
mgIs18 otIs76 bx80 kenEx[p-elt-3::efn-4 sur-5::GFP ttx-3::RFP] 1A at:  
*all injected with same microinjection mix 
plasmid [stock] vol. to add [final] 
pelt-3::efn-4 (pMH833) 150ng/μl 0.7μl 5ng/μl 
psur-5::GFP 140ng/μl 2.6μl 20ng/μl 
pttx-3::RFP 340ng/μl 1.5μl 25ng/μl 
pBSII -ng/μl -μl -ng/μl 
H2O  15.2μl  
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